Profil
Ann-Sofie Sternås is currently working as the Director of Intellectual Property at Akinion Pharmaceuticals AB. Previously, she held positions as the Director of Intellectual Property at Axelar AB, Principal at AstraZeneca AB, and Vice President of Intellectual Property Rights at ClanoTech AB.
Aktiva positioner av Ann-Sofie Sternås
| Företag | Position | Start |
|---|---|---|
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Företagsledare/Principal | - |
Tidigare kända positioner av Ann-Sofie Sternås
| Företag | Position | Slut |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Företagsledare/Principal | - |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Företagsledare/Principal | - |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Företagsledare/Principal | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
















